BioNeutral Group Inc. | Cash Flow
Fiscal year is November-October. All values USD Thousands.
2009
2010
2011
2012
2013
Net Income before Extraordinaries
13,451.30
3,501.60
2,819.00
2,606.40
3,190.80
Depreciation, Depletion & Amortization
627.30
696.80
706.80
708.90
708.90
Other Funds
10,896.60
167.50
631.40
315.00
715.70
Funds from Operations
1,927.50
2,637.40
1,480.80
1,582.50
1,766.20
Changes in Working Capital
305.70
902.10
599.60
223.40
1,067.40
Net Operating Cash Flow
1,621.80
1,735.30
881.20
1,359.00
698.80
Capital Expenditures
8.50
-
-
-
-
Net Investing Cash Flow
8.50
-
-
-
-
Issuance/Reduction of Debt, Net
5.80
1,475.00
482.50
356.50
673.80
Net Financing Cash Flow
1,684.00
1,655.00
825.00
1,356.50
698.80
Net Change in Cash
53.70
80.30
56.20
2.50
0.00
Free Cash Flow
1,621.80
1,735.30
881.20
1,359.00
698.80
Change in Capital Stock
1,689.80
180.00
342.50
1,000.00
25.00
About BioNeutral Group
View Profile
